Dimension Investor Sues To Block $151M Ultragenyx Merger
A Dimension Therapeutics Inc. shareholder urged a Massachusetts federal court Wednesday to block Ultragenyx Pharmaceutical Inc.'s proposed $151 million acquisition of the company, alleging Dimension withheld material information from the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article